Archives
-
Dextromethorphan Hydrobromide in Neuroprotection Assays
2026-09-21
Build more informative excitotoxicity experiments with Dextromethorphan hydrobromide by separating NMDA receptor effects from voltage-operated ion-channel modulation. This workflow connects concentration-response screening, orthogonal neuronal readouts, and cerebral ischemia model design while clearly distinguishing product evidence from proposed starting conditions.
-
Tetraethylammonium chloride K+ Channel Assays
2026-09-20
Tetraethylammonium chloride (TEAC) offers a practical way to interrogate potassium-channel pore conduction, mutant-channel behavior, and vascular responses. This workflow connects TEAC pharmacology with 86Rb efflux, patch-clamp, insulin-release, and isolated-artery assays while emphasizing controls that prevent receptor and ion-channel mechanisms from being confused.
-
Mecamylamine Hydrochloride as a Circuit Probe
2026-09-19
Mecamylamine hydrochloride can turn broad cholinergic observations into testable receptor-level hypotheses. This article presents a confound-aware framework for applying mecamylamine to gut–brain, seizure, and neuropsychiatric disorder research.
-
Amikacin (BAY416651) Resistance Workflows
2026-09-18
Amikacin (BAY416651) supports more than routine susceptibility testing: it can connect bacterial protein synthesis inhibition with enzyme-specific resistance, plasmid localization, and transmission assays. This research-focused workflow combines practical stock handling with the molecular framework used to study carbapenem-resistant Enterobacter cloacae.
-
Verapamil in Hypoxia-Driven Inflammation
2026-09-18
Verapamil ((±)-Verapamil) provides a practical perturbation tool for testing how prolonged hypoxia engages the ROS/TXNIP/NLRP3 axis in urothelial cells. This guide translates the reference findings into an executable workflow while highlighting controls for calcium-channel, P-glycoprotein, solvent, and exposure-time confounding.
-
Lamotrigine: Sodium Channel Research Guide
2026-09-17
Lamotrigine is a high-purity sodium channel blocker research compound identified as 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine. Its reported 5-HT activity, solubility profile, and compatibility with neuronal and cardiomyocyte assays support controlled epilepsy and cardiac sodium current modulation studies.
-
CLCC1 and Herpesvirus Nuclear Egress
2026-09-17
A 2024 bioRxiv preprint identifies CLCC1 as an essential host factor for the membrane-fusion step of herpesvirus nuclear egress, linking viral capsid release to nuclear-envelope morphogenesis. Its CRISPR-screen and cell-biology findings provide a framework for distinguishing viral budding defects from post-budding fusion defects, while remaining subject to the limitations of an unreviewed study.
-
Tetrandrine: From Ion Channels to Assay Design
2026-09-16
Tetrandrine research spans calcium-channel biology, inflammation, neuroscience, and cancer models. This evidence-led guide shows how to connect membrane pharmacology with structure-based screening while avoiding overinterpretation of computational findings.
-
Psora 4: Interpreting Kv1.3 Blockade in T Cells
2026-09-16
Psora 4 is a selective Kv1.3 blocker for dissecting T-cell calcium signaling and effector-memory responses. This article explains how KCNE4-dependent channel architecture, endpoint timing, and cell-state controls can improve the interpretation of Psora 4 experiments.
-
NSP15 Inhibitor Screening: Thymopentin and Oleuropein
2026-09-15
A 2021 structure-based study screened a natural-product library against the SARS-CoV-2 NSP15 endoribonuclease and identified thymopentin and oleuropein as the highest-ranked candidates. Molecular dynamics simulations supported stable protein–ligand complexes, but the findings remain computational and require biochemical, cellular, and infection-model validation.
-
Methylprednisolone Sodium Succinate Workflows
2026-09-15
Build concentration-aware workflows for cytokine suppression, oxidative-burst testing, and apoptosis induction in tumor cells with a research-grade synthetic corticosteroid. This guide connects product handling with assay controls, translational interpretation, and practical troubleshooting for inflammation and immunology studies.
-
DIDS: Workflow for Channel and Tumor Assays
2026-09-14
DIDS connects chloride-transport pharmacology with vascular, sensory, neuroprotection, and near-death tumor-cell workflows. This guide emphasizes formulation control, matched controls, and assay designs that separate broad anion-transport effects from pathway-specific biology.
-
Dasatinib Monohydrate in Tumor Assembloids
2026-09-14
Use Dasatinib Monohydrate as a pathway-resolved kinase probe in matched gastric tumor organoids and stromal assembloids, not simply as a cytotoxicity reagent. This workflow separates epithelial sensitivity from microenvironment-mediated resistance while extending BMS-354825 research into patient-specific models.
-
From Reporter Signal to mRNA Platform Strategy
2026-09-13
Reporter mRNA is more than a fluorescence reagent: it is a practical calibration layer for separating delivery, intracellular stability, innate sensing, and translation. This article examines how EZ Cap™ EGFP mRNA (5-moUTP) can support mechanistic assay design and translational decisions, while connecting its architecture to emerging advances in mRNA loading and lipid nanoparticle engineering.
-
Tetrandrine: From Calcium Signals to Translation
2026-09-12
A translational framework for using the Tetrandrine alkaloid as a mechanistic perturbation tool in calcium signaling, inflammation, neuroscience, and cancer biology, while separating established pharmacology from computational antiviral hypotheses.